ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — Financial Flexibility Index
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Financial Flexibility Index of 0.20x as of June 2025. Free cash flow of €10.21 Billion (operating CF €5.16 Billion minus capex €5.05 Billion) represents 0% of total liabilities (€51.00 Billion). Also explore LDZU shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ASPEN PHAR.UN.ADR /1 O.N. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for ASPEN PHAR.UN.ADR /1 O.N. across 4 annual periods. See net asset quality index of ASPEN PHAR.UN.ADR /1 O.N. to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for ASPEN PHAR.UN.ADR /1 O.N. (2022–2025)
Year-by-year free cash flow to debt coverage for ASPEN PHAR.UN.ADR /1 O.N.. For the full company profile including market capitalisation, see ASPEN PHAR.UN.ADR /1 O.N. market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | €10.21 Billion | €5.16 Billion | €51.00 Billion | ▼ -7.7% |
| 2024 | 0.22x | €11.76 Billion | €6.22 Billion | €54.20 Billion | ▲ +19.8% |
| 2023 | 0.18x | €8.70 Billion | €5.52 Billion | €48.05 Billion | ▼ -9.3% |
| 2022 | 0.20x | €8.07 Billion | €5.37 Billion | €40.43 Billion | — |